Standardization and Documentation of Surgical and Pathologic Variables in a Multi-Institutional Trial of Adjuvant Therapy for Pancreatic Cancer: Results From ACOSOG Z5031

被引：0
|
作者：
Katz, M. H. [1 ]
Merchant, N. B. [2 ]
Brower, S. [3 ]
Campbel, M. [4 ]
Posner, M. [5 ]
Traverso, L. W. [6 ]
Abrams, R. A. [7 ]
Picozzi, V. J. [6 ]
Pisters, P. W. [8 ]
机构：
[1] UC Irvine, Orange, CA USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[3] Mem Hlth Univ Med Ctr, Savannah, GA 31404 USA
[4] Mayo Clin, Rochester, MN USA
[5] Univ Chicago, Chicago, IL 60637 USA
[6] Virginia Mason Med Ctr, Seattle, WA 98101 USA
[7] Rush Univ, Med Ctr, Chicago, IL 60612 USA
[8] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2010年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [41] Excellent acute toxicity outcomes with proton therapy for partial breast irradiation in early stage breast cancer: Initial results of a multi-institutional phase II trial
    Choi, J. Isabelle
    Chang, Andrew L.
    CANCER RESEARCH, 2018, 78 (04)
  • [42] Quality of Life (QOL) Outcomes Through 3 Years After Stereotactic Body Radiation Therapy (SBRT) for Early Prostate Cancer: Results From a Multi-institutional Phase 2 Trial
    Chen, R. C.
    Wong, D.
    Medberry, C.
    Underhill, K.
    Fuller, D. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S73 - S73
  • [43] Low Dose Upper Abdominal Radiation Therapy (LD-UART) Potentiates Gemcitabine in Patients with Advanced, Unresectable Pancreatic Cancer (PC): Final Results from a Phase II Multi-Institutional Study
    Sharma, N. K.
    Pandya, N.
    Wong, R.
    Herman, J.
    Hanna, N. N.
    Laheru, D. A.
    Major, P.
    Alexander, H. R.
    Kennedy, N.
    Regine, W. F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S103 - S103
  • [44] Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series
    Fossati, Nicola
    Karnes, R. Jeffrey
    Boorjian, Stephen A.
    Moschini, Marco
    Morlacco, Alessandro
    Bossi, Alberto
    Seisen, Thomas
    Cozzarini, Cesare
    Fiorino, Claudio
    Chiorda, Barbara Noris
    Gandaglia, Giorgio
    Dell'Oglio, Paolo
    Joniau, Steven
    Tosco, Lorenzo
    Shariat, Shahrokh
    Goldner, Gregor
    Hinkelbein, Wolfgang
    Bartkowiak, Detlef
    Haustermans, Karin
    Tombal, Bertrand
    Montorsi, Francesco
    Van Poppel, Hein
    Wiegel, Thomas
    Briganti, Alberto
    EUROPEAN UROLOGY, 2017, 71 (06) : 886 - 893
  • [45] Health-Related Quality of Life After Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Results From a Multi-institutional Consortium of Prospective Trials
    King, Christopher R.
    Collins, Sean
    Fuller, Donald
    Wang, Pin-Chieh
    Kupelian, Patrick
    Steinberg, Michael
    Katz, Alan
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (05): : 939 - 945
  • [46] Multi-Institutional Randomized Double-Blind Phase II Trial of Everolimus vs. Placebo as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)
    Nathan, C. A. O.
    Hayes, D. N.
    Harismendy, O.
    Flores, J.
    Moore-Medlin, T.
    Gutkind, J. S.
    Neupane, P.
    Mills, G.
    Sargi, Z. B.
    Seiwert, T. Y.
    Grilley-Olson, J.
    Day, T.
    Gillison, M.
    Wade, J.
    Feldman, L.
    Jha, G.
    Kozloff, M.
    O'Leary, M.
    Worden, F.
    Cohen, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1116 - 1116
  • [47] Sunitinib plus hormone ablation and radiation therapy for patients with high-risk localized prostate cancer: Results from a multi-institutional phase I study
    Corn, Paul G.
    Song, Danny
    Heath, Elisabeth
    Maier, Jordan
    Meyn, Raymond
    Kuban, Deborah
    DiPetrillo, Thomas
    Mathew, Paul
    CANCER RESEARCH, 2012, 72
  • [48] Sunitinib Plus Androgen Deprivation and Radiation Therapy for Patients With Localized High-Risk Prostate Cancer: Results From a Multi-institutional Phase 1 Study
    Corn, Paul G.
    Song, Danny Y.
    Heath, Elisabeth
    Maier, Jordan
    Meyn, Raymond
    Kuban, Deborah
    DePetrillo, Thomas A.
    Mathew, Paul
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (03): : 540 - 545
  • [49] A prospective feasibility study of one-year administration of adjuvant S-1 therapy for resected biliary tract cancer in a multi-institutional trial (Tokyo Study Group for Biliary Cancer: TOSBIC01)
    Osamu Itano
    Yusuke Takemura
    Norihiro Kishida
    Eiji Tamagawa
    Hiroharu Shinozaki
    Ken Ikeda
    Hidejiro Urakami
    Shigenori Ei
    Shigeo Hayatsu
    Keiichi Suzuki
    Tadayuki Sakuragawa
    Masatsugu Ishii
    Masaya Shito
    Koichi Aiura
    Hiroto Fujisaki
    Kiminori Takano
    Junichi Matsui
    Takuya Minagawa
    Masahiro Shinoda
    Minoru Kitago
    Yuta Abe
    Hiroshi Yagi
    Go Oshima
    Shutaro Hori
    Yuko Kitagawa
    BMC Cancer, 20
  • [50] A prospective feasibility study of one-year administration of adjuvant S-1 therapy for resected biliary tract cancer in a multi-institutional trial (Tokyo Study Group for Biliary Cancer: TOSBIC01)
    Itano, Osamu
    Takemura, Yusuke
    Kishida, Norihiro
    Tamagawa, Eiji
    Shinozaki, Hiroharu
    Ikeda, Ken
    Urakami, Hidejiro
    Ei, Shigenori
    Hayatsu, Shigeo
    Suzuki, Keiichi
    Sakuragawa, Tadayuki
    Ishii, Masatsugu
    Shito, Masaya
    Aiura, Koichi
    Fujisaki, Hiroto
    Takano, Kiminori
    Matsui, Junichi
    Minagawa, Takuya
    Shinoda, Masahiro
    Kitago, Minoru
    Abe, Yuta
    Yagi, Hiroshi
    Oshima, Go
    Hori, Shutaro
    Kitagawa, Yuko
    BMC CANCER, 2020, 20 (01)
12345